Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Lluís Nisa; Paola Francica; Roland Giger; Matúš Medo; Olgun Elicin; Manja Friese-Hamim; Claudia Wilm; Christopher Stroh; Beat Bojaxhiu; Aurélie Quintin; Marco D. Caversaccio; Matthias S. Dettmer; Mélanie Buchwalder; Tess M. Brodie; Daniel M. Aebersold; Yitzhak Zimmer; Thomas E. Carey; Michaela Medová

doi:10.1158/1535-7163.MCT-18-1274

Cancer Biology and Translational Studies

Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Lluís Nisa, Paola Francica, Roland Giger, Matúš Medo, Olgun Elicin, Manja Friese-Hamim, Claudia Wilm, Christopher Stroh, Beat Bojaxhiu, Aurélie Quintin, Marco D. Caversaccio, Matthias S. Dettmer, Mélanie Buchwalder, Tess M. Brodie, Daniel M. Aebersold, Yitzhak Zimmer, Thomas E. Carey and Michaela Medová

Lluís Nisa

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paola Francica

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roland Giger

3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matúš Medo

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olgun Elicin

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Olgun Elicin

Manja Friese-Hamim

4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claudia Wilm

4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher Stroh

4Translational Innovation Platform Oncology, Merck HealthCare KGaA, Darmstadt, Germany.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Beat Bojaxhiu

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aurélie Quintin

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marco D. Caversaccio

3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias S. Dettmer

5Institute of Pathology, University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Matthias S. Dettmer

Mélanie Buchwalder

3Department of Otorhinolaryngology – Head and Neck Surgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

5Institute of Pathology, University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tess M. Brodie

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

6Mass Cytometry Facility, University of Zurich, Zurich, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel M. Aebersold

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Daniel M. Aebersold

Yitzhak Zimmer

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas E. Carey

7Department of Otolaryngology – Head and Neck Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan.

8Comprehensive Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Thomas E. Carey

Michaela Medová

1Department for BioMedical Research, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

2Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michaela Medová
For correspondence: michaela.medova@dbmr.unibe.ch

DOI: 10.1158/1535-7163.MCT-18-1274 Published February 2020

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

February 2020
Volume 19, Issue 2

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Message Subject (Your Name) has forwarded a page to you from Molecular Cancer Therapeutics

Message Body (Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Mol Cancer Ther February 1 2020 (19) (2) 614-626; DOI: 10.1158/1535-7163.MCT-18-1274

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Mol Cancer Ther February 1 2020 (19) (2) 614-626; DOI: 10.1158/1535-7163.MCT-18-1274

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Main menu

User menu

Search

Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Purchase access

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info for

About MCT